Oral histoplasmosis after radiation therapy for laryngeal squamous cell carcinoma

Journal of the American Academy of Dermatology

Volumn 56, Issue 5, 2007, Pages 871-873

  Ezzedine, Khaled ^a   Accoceberry, Isabelle ^b   Malvy, Denis ^a  

^a Infectious Diseases and Tropical Medicine   (Belgium)

^b University Hospital Center   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DYSPHAGIA; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOARSENESS; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MALE; ODYNOPHAGIA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SYMPTOM; WEIGHT REDUCTION;

AGED; ANTIFUNGAL AGENTS; CARCINOMA, SQUAMOUS CELL; HISTOPLASMOSIS; HUMANS; ITRACONAZOLE; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MOUTH DISEASES; RADIOTHERAPY;

EID: 34147169985     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.10.026     Document Type: Article

References (14)

1. Cano M.V., and Hajjeh R.A. The epidemiology of histoplasmosis: a review. Semin Respir Infect 16 (2001) 109-118
2. Woods J.P., Heinecke E.L., Luecke J.W., Maldonado E., Ng J.Z., Retallack D.M., et al. Pathogenesis of Histoplasma capsulatum. Semin Respir Infect 16 (2001) 91-101
3. Manfredi R., Mazzoni A., Nanetti A., and Chiodo F. Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration. Eur J Epidemiol 10 (1994) 675-681
4. Gascon J., Torres J.M., Jiménez M., Mejias T., Trivino L., Gobbi F., et al. Histoplasmosis infection in Spanish travellers to Latin America. Eur J Clin Microbiol Infect Dis 12 (2005) 839-841
5. Panackal A.A., Hajjeh R.A., Cetron M.S., and Warnock D.W. Fungal infections among returning travellers. Clin Infect Dis 35 (2002) 1088-1095
6. Jain V.V., Evans T., and Peterson M.W. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor α in a patient from a non-endemic area. Respir Med 100 (2006) 1291-1295
7. Desmet P., Vogelaers D., and Afschrift M. Progressive disseminated histoplasmosis 10 years after return out of Africa in an immunocompetent host. Acta Clin Belg 59 (2004) 274-278
8. Subramanian S., Abraham O.C., Rupati P., Zachariah A., Mathews M.S., and Mathai D. Disseminated histoplasmosis. J Assoc Physicians India 53 (2005) 185-189
9. Hernandez S.L., Lopez de Blanc A.S., Sambuelli R.H., Roland H., Cornelli C., Lattanzi V., et al. Oral histoplasmosis associated with HIV infection: a comparative study. J Oral Pathol Med 33 (2004) 445-450
10. Alcure M.L., Di Hipolito Jr. O., Paes de Almeida O., Bouilhah H., and Lopes M.C. Oral histoplasmosis in an HIV-negative patient. Oral Med Oral Pathol Oral Endod 101 (2006) E33-E36
11. Mignogna M.D., Fedele S., Lo Russo L., Ruoppo E., and Lo Muzio L.A. A case of oral localized histoplasmosis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 20 (2001) 753-755
12. Epstein J.B., Freilich M.M., and Le N.D. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 73 (1993) 169-174
13. Negroni R., Robles A.M., Arechavala A., and Taborda A. Itraconazole in human histoplasmosis. Mycoses 32 (1989) 123-130
14. Doughan A. Disseminated histoplasmosis: case report and brief review. Travel Med Infect Dis doi:10.1016/j.tmaid.2006.01.013. Published online April 19, 2006.